Flu Drug Fighting Resistant Strains to Seek U.S. Approval

The first new type of flu drug in more than a decade could seek U.S. regulatory approval as early as next year, aided by U.S. government efforts to combat pandemics and biological threats.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.